Nicholas Strouthidis, Hari Jayaram,Michael O’Gallager, Matthew Green, Mark Wilkins
To describe the glaucoma management inpatients who have undergone implantation of the TypeI Boston Keratoprosthesis (KPro) at Moor?elds EyeHospital.
Retrospective note review of NHS (public)patients undergoing KPro procedures 2011–2014.
26 patients underwent KPro implantationunder the care of a single corneal consultant (MW). 11(42%) had pre-existing glaucoma, 6 (23%) had pre-existing functioning anterior chamber Baerveldt tubesand a further 3 had pars plana Baerveldts implantedeither before, during or after KPro surgery. One patientwith pre-existing Baervledt went blind from funneldetachment. A further 2 had undergone previous glau-coma surgeries (multiple diodes or trabeculectomies)and lost vision from disc progression post-KPro. Ofthe 15 without pre-existing glaucoma, 1 was lost tofollow-up and 1 KPro extruded and was replaced witha penetrating keratoplasty. 8 (31%) remain off drops,and 3 have required tube implantation. Of the latter 3,one went blind because of refractory high IOP.
KPro surgery has the potential to giveuseful sight to patients in whom there are no otherviable options. However, many of these patients havecomplex multiple ophthalmic pathologies, which maketheir post-operative management dif?cult and can leadto poor outcomes in some cases. It is important to havean integrated management plan, particularly for glau-coma management. In light of our experience, we haveestablished a combined glaucoma/KPro clinic in thehope of managing potential glaucoma problems aprioriand to establish the best methods of monitoring thesepatients after KPro implantation.
COMPARISON OF RANIBIZUMAB AND AFLIBERCEPT IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED FOLLOWING A ?TREAT AND EXTEND? PROTOCOL: EFFICACY VARIABLES FROM THE PRE-SPECIFIED 12- MONTH INTERIM ANALYSIS OF THE RIVAL STUDY